All Stories

  1. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index
  2. A 55-Year-Old Male Presenting With Altered Mental Status: A Complicated Case of Intracranial Aneurysm
  3. Diagnostic and treatment workup for IgG4-related disease
  4. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease
  5. Response to: ‘Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years’ by Yamamotoet al
  6. Rituximab for IgG4-related disease: a prospective, open-label trial
  7. Reply
  8. Reply
  9. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
  10. Brief Report: Spuriously Low Serum IgG4 Concentrations Caused by the Prozone Phenomenon in Patients With IgG4-Related Disease
  11. IgG4-Related Disease
  12. IgG4-Related Disease and Hypertrophic Pachymeningitis
  13. Diagnostic guidelines for IgG4-related disease with a focus on histopathological criteria
  14. Does Autoimmune Pancreatitis Increase the Risk of Pancreatic Carcinoma?
  15. Rethinking Ormond’s Disease
  16. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations
  17. Consensus statement on the pathology of IgG4-related disease
  18. IgG4-related disease presenting as recurrent mastoiditis
  19. Development of an IgG4-RD Responder Index
  20. The latest on IgG4-RD
  21. Rituximab for the Treatment of IgG4-Related Disease
  22. IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor
  23. IgG4-Related Systemic Disease as a Cause of “Idiopathic” Orbital Inflammation, Including Orbital Myositis, and Trigeminal Nerve Involvement
  24. The Clinical and Pathological Features of IgG4-Related Disease
  25. Cutaneous Immunoglobulin G4-Related Systemic Disease
  26. Eosinophilic Angiocentric Fibrosis Is a Form of IgG4-related Systemic Disease
  27. A clinical overview of IgG4-related systemic disease
  28. IgG4-related systemic disease: the age of discovery
  29. Treatment approaches to IgG4-related systemic disease
  30. Pancreatic Disease in Sjögren’s Syndrome and IgG4-Related Disease
  31. Subclassification of Autoimmune Pancreatitis
  32. A 22-year-old woman with severe headaches, vomiting, and tonic-clonic seizures
  33. A 44-year-old woman with cutaneous bullae and extensive skin necrosis
  34. Riedel's Thyroiditis and Multifocal Fibrosclerosis are part of the IgG4-related systemic disease spectrum
  35. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases
  36. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
  37. IgG4-related systemic disease and lymphoplasmacytic aortitis
  38. Painless jaundice with serial multi-organ dysfunction
  39. Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis
  40. Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis
  41. Su.26. PDL1 Regulates Autoimmunity By Limiting Expansion of Autoreactive Th1 Cells and Mediates Resistance to Diabetes in Nod Mice